Genericsweb Pty Ltd.
Established in 1999, GenericsWeb has customers in over 40 countries including legal practices, government departments, consultants and generic manufacturers. GenericsWeb’s Pipeline Patent Intelligence provides the most comprehensive, relevant and accurate patent information available which stems from full dedication to the industry, extensive experience and investment in customer research.
... , by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff ... the world's key territories (see 'search coverage' below) Identifies patents covering molecule, formulation, process, use, combination and assay techniques ( ...
Apr, 2013... families protecting the active ingredient per se. Family DK113585A (12/03/1985) claims Insulin Glargine generally. European patent EP0254516 was extended by supplementary protection ... . The patent term in the US will run until February 2015. Insulin pen delivery devices and are owned by companies other than ...
Apr, 2013... or other procedures; Sedation of intubated/mechanically ventilated ICU patients during treatment Dexmedetomidine innovator: Hospira (Precedex); Orion (Dexdor) Examples of information found in this online report include: Includes key patent publications for 7 countries (see list below) Contains SPC ...
Feb, 2013... by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country ... Western Europe NAT/SPC Spain Western Europe SPC Other key information contained in the report: Summary of dosage forms, strengths, indications ...
Feb, 2013... by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country ... Western Europe NAT/SPC Spain Western Europe SPC Other key information contained in the report: Summary of dosage forms, strengths, indications ...
Feb, 2013... by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country ... Western Europe NAT/SPC Spain Western Europe SPC Other key information contained in the report: Summary of dosage forms, strengths, indications ...
Feb, 2013... in Dextrose 5%, Ancef in Plastic Container, Ancef in Sodium Chloride 0.9% in Plastic Container); B Braun (Cefazolin and Dextrose) Examples of information found in this online report include: Includes key patent publications for 7 countries (see list below) Contains SPC protection for every EU state plus ...
Feb, 2013... : Treatment of type 2 diabetes mellitus, optionally in combination with glucose-lowering agents Canagliflozin innovator: Janssen Examples of information found in this online report include: Includes key patent publications for 7 countries (see list below) Contains SPC protection for every EU state plus ...
Feb, 2013... by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country ... Western Europe NAT/SPC Spain Western Europe SPC Other key information contained in the report: Summary of dosage forms, strengths, indications ...
Feb, 2013... prior systemic therapy Axitinib innovator: Pfizer (Inlyta) Examples of information found in this online report include: Includes key patent publications for ... Western Europe NAT/SPC Spain Western Europe SPC Other key information contained in the report: Summary of dosage forms, strengths, indications ...
Feb, 2013... combination with Peginterferon alfa and Ribavirin Telaprevir innovator: Vertex Pharm (Incivek) EXAMPLES OF INFORMATION FOUND IN THIS ONLINE REPORT INCLUDE: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term ...
Feb, 2013... other antiretroviral agents Rilpivirine innovator: Tibotec (Edurant) EXAMPLES OF INFORMATION FOUND IN THIS ONLINE REPORT INCLUDE: Includes key patent publications for ... Region Extensions Australia Asia-Pacific S70 Canada Americas N/A USA Americas S156 Germany Western Europe SPC Great Britain Western Europe ...
Feb, 2013... registries enabling data verification The 'Key Patent Indicator' enables easy identification of key patent, SPC and data protection expiry information ... limitations. These graphics are intended to provide only a summary of the patent filings; specific details of the filings should be investigated through the ...
Feb, 2013... ) MDV-3100 (Enzalutamide) indications: Treatment of prostate cancer MDV-3100 (Enzalutamide) innovator: Medivation (Enzalutamide); Astellas Pharma (Enzalutamide) EXAMPLES OF INFORMATION FOUND IN THIS ONLINE REPORT INCLUDE: Includes key patent publications for 44 countries (see list below) Contains SPC ...
Feb, 2013... covers Lisdexamfetamine Lisdexamfetamine indications: Treatment of attention deficit hyperactivity disorder (ADHD) Lisdexamfetamine Shire (Vyvanse) EXAMPLES OF INFORMATION FOUND IN THIS ONLINE REPORT INCLUDE: Includes key patent publications for 7 countries (see list below) Contains SPC protection for ...
Feb, 2013... deficit hyperactivity disorder (ADHD) Lisdexamfetamine innovator: Shire (Vyvanse) EXAMPLES OF INFORMATION FOUND IN THIS ONLINE REPORT INCLUDE: Includes key patent publications for ... France Western Europe NAT/SPC Spain Western Europe SPC South Africa Africa N/A China Asia-Pacific N/A Japan Asia-Pacific S67 ...
Feb, 2013... with Capecitabine Ixabepilone innovator: Bristol-Myers Squibb (Ixempra) EXAMPLES OF INFORMATION FOUND IN THIS ONLINE REPORT INCLUDE: Includes key patent publications ... Region Extensions Australia Asia-Pacific S70 Canada Americas N/A USA Americas S156 Germany Western Europe SPC Great Britain Western Europe ...
Feb, 2013... registries enabling data verification The 'Key Patent Indicator' enables easy identification of key patent, SPC and data protection expiry information ... limitations. These graphics are intended to provide only a summary of the patent filings; specific details of the filings should be investigated through the ...
Feb, 2013... registries enabling data verification The 'Key Patent Indicator' enables easy identification of key patent, SPC and data protection expiry information ... limitations. These graphics are intended to provide only a summary of the patent filings; specific details of the filings should be investigated through the ...
Feb, 2013... Allopurinol, steroids and anti-emetics Clofarabine innovator: Genzyme (Clolar, Evoltra) EXAMPLES OF INFORMATION FOUND IN THIS ONLINE REPORT INCLUDE: Includes key patent publications for 44 countries (see list below) Contains SPC protection for every EU state plus patent term ...
Feb, 2013